| Year |
Citation |
Score |
| 2023 |
Zhang X, Sarkar S, Ashokan A, Surnar B, Kolishetti N, Dhar S. All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy. Bioconjugate Chemistry. 34: 1122-1129. PMID 37279374 DOI: 10.1021/acs.bioconjchem.3c00152 |
0.619 |
|
| 2022 |
Shah AS, Surnar B, Kolishetti N, Dhar S. Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies. Accounts of Materials Research. 3: 283-296. PMID 37091880 DOI: 10.1021/accountsmr.1c00178 |
0.677 |
|
| 2021 |
Costoya J, Surnar B, Kalathil AA, Kolishetti N, Dhar S. Controlled release nanoplatforms for three commonly used chemotherapeutics. Molecular Aspects of Medicine. 101043. PMID 34920863 DOI: 10.1016/j.mam.2021.101043 |
0.636 |
|
| 2021 |
Kolishetti N, Vashist A, Arias AY, Atluri V, Dhar S, Nair M. Recent advances, status, and opportunities of magneto-electric nanocarriers for biomedical applications. Molecular Aspects of Medicine. 101046. PMID 34743901 DOI: 10.1016/j.mam.2021.101046 |
0.552 |
|
| 2021 |
Surnar B, Shah AS, Guin S, Kolishetti N, Fornoni A, Dhar S. Blending of Designer Synthetic Polymers to a Dual Targeted Nanoformulation for SARS-CoV-2 Associated Kidney Damage. Biomacromolecules. PMID 34492195 DOI: 10.1021/acs.biomac.1c00799 |
0.613 |
|
| 2021 |
Surnar B, Shah AS, Park M, Kalathil AA, Kamran MZ, Ramirez Jaime R, Toborek M, Nair M, Kolishetti N, Dhar S. Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress. Acs Nano. PMID 34355558 DOI: 10.1021/acsnano.0c09553 |
0.592 |
|
| 2020 |
Kolb D, Kolishetti N, Surnar B, Sarkar S, Guin S, Shah AS, Dhar S. Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration. Acs Nano. PMID 32706241 DOI: 10.1021/Acsnano.9B10037 |
0.61 |
|
| 2019 |
Surnar B, Kamran MZ, Shah AS, Basu U, Kolishetti N, Deo S, Jayaweera DT, Daunert S, Dhar S. Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus. Acs Nano. PMID 31603314 DOI: 10.1021/Acsnano.9B02807 |
0.644 |
|
| 2018 |
Surnar B, Basu U, Banik B, Ahmad A, Marples B, Kolishetti N, Dhar S. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection. Proceedings of the National Academy of Sciences of the United States of America. PMID 30530697 DOI: 10.1073/Pnas.1816429115 |
0.614 |
|
| 2018 |
Pathak RK, Basu U, Ahmad A, Sarkar S, Kumar A, Surnar B, Ansari S, Wilczek K, Ivan ME, Marples B, Kolishetti N, Dhar S. A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. Biomaterials. 187: 117-129. PMID 30336364 DOI: 10.1016/J.Biomaterials.2018.08.062 |
0.624 |
|
| 2018 |
Surnar B, Kolishetti N, Basu U, Ahmad A, Goka E, Marples B, Kolb D, Lippman M, Dhar S. Reduction of cisplatin induced ototoxicity without compromising its antitumor activity. Biochemistry. PMID 30281285 DOI: 10.1021/Acs.Biochem.8B00712 |
0.606 |
|
| 2017 |
Banik B, Wen R, Marrache S, Kumar A, Kolishetti N, Howerth EW, Dhar S. Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution. Nanoscale. PMID 29218349 DOI: 10.1039/C7Nr06295H |
0.61 |
|
| 2017 |
Pathak RK, Wen R, Kolishetti N, Dhar S. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. Molecular Cancer Therapeutics. PMID 28148716 DOI: 10.1158/1535-7163.Mct-16-0445 |
0.664 |
|
| 2016 |
Wen R, Banik B, Pathak RK, Kumar A, Kolishetti N, Dhar S. Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Advanced Drug Delivery Reviews. PMID 26776231 DOI: 10.1016/J.Addr.2015.12.024 |
0.612 |
|
| 2015 |
Hudlikar MS, Li X, Gagarinov IA, Kolishetti N, Wolfert MA, Boons GJ. Controlled Multi-functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 26683093 DOI: 10.1002/Chem.201503999 |
0.543 |
|
| 2015 |
Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C, Kohler RH, Iwamoto Y, Yang KS, Askevold B, Kolishetti N, Pittet M, Lippard SJ, Farokhzad OC, Weissleder R. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nature Communications. 6: 8692. PMID 26503691 DOI: 10.1038/Ncomms9692 |
0.56 |
|
| 2015 |
Feldhaeusser B, Platt SR, Marrache S, Kolishetti N, Pathak RK, Montgomery DJ, Reno LR, Howerth E, Dhar S. Evaluation of nanoparticle delivered cisplatin in beagles. Nanoscale. 7: 13822-30. PMID 26234400 DOI: 10.1039/C5Nr03447G |
0.636 |
|
| 2015 |
Pathak RK, Kolishetti N, Dhar S. Targeted nanoparticles in mitochondrial medicine. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 7: 315-29. PMID 25348382 DOI: 10.1002/Wnan.1305 |
0.647 |
|
| 2015 |
Feldhaeusser B, Platt SR, Marrache S, Kolishetti N, Pathak RK, Montgomery DJ, Reno LR, Howerth E, Dhar S. Evaluation of nanoparticle delivered cisplatin in beagles Nanoscale. 7: 13822-13830. DOI: 10.1039/c5nr03447g |
0.599 |
|
| 2014 |
Ledin PA, Kolishetti N, Hudlikar MS, Boons GJ. Exploring strain-promoted 1,3-dipolar cycloadditions of end functionalized polymers. Chemistry (Weinheim An Der Bergstrasse, Germany). 20: 8753-60. PMID 24906200 DOI: 10.1002/Chem.201402225 |
0.417 |
|
| 2014 |
Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC. Development of therapeutic polymeric nanoparticles for the resolution of inflammation. Advanced Healthcare Materials. 3: 1448-56. PMID 24659608 DOI: 10.1002/Adhm.201300688 |
0.537 |
|
| 2013 |
Ledin PA, Kolishetti N, Boons GJ. Multi-Functionalization of Polymers by Strain-Promoted Cycloadditions. Macromolecules. 46: 7759-7768. PMID 24511157 DOI: 10.1021/Ma400913A |
0.387 |
|
| 2013 |
Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases. Current Medicinal Chemistry. 20: 3500-14. PMID 23834187 DOI: 10.2174/0929867311320280007 |
0.673 |
|
| 2013 |
Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases Current Medicinal Chemistry. 20: 3500-3514. DOI: 10.2174/0929867311320280007 |
0.562 |
|
| 2012 |
Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ. α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. Acs Nano. 6: 4530-9. PMID 22584163 DOI: 10.1021/Nn301148E |
0.617 |
|
| 2011 |
Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 108: 1850-5. PMID 21233423 DOI: 10.1073/Pnas.1011379108 |
0.699 |
|
| 2010 |
Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proceedings of the National Academy of Sciences of the United States of America. 107: 17939-44. PMID 20921363 DOI: 10.1073/Pnas.1011368107 |
0.74 |
|
| 2010 |
Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, von Andrian U, Farokhzad OC. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (London, England). 5: 269-85. PMID 20148638 DOI: 10.2217/Nnm.10.1 |
0.525 |
|
| 2008 |
Kolishetti N, Faust R. Structure−Reactivity Scales in Carbocationic Polymerizations Macromolecules. 41: 9025-9029. DOI: 10.1021/Ma801669T |
0.447 |
|
| 2008 |
Kolishetti N, Faust R. Relative Reactivities of Isobutylene, Styrene, and Ring-Substituted Styrenes in Cationic Polymerizations Macromolecules. 41: 3842-3851. DOI: 10.1021/Ma800120H |
0.455 |
|
| Show low-probability matches. |